Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Drugpatentwatch trametinib?Defense strategy against generic in niche market?What are alcohol's effects on ozempic?How much is mebendazole?How does protein binding influence lipitor's removal via kidneys?
See the DrugPatentWatch profile for cosentyx
Cosentyx (secukinumab) has an elimination half-life of about 27 days in adults. [1]
Because secukinumab remains in the body for weeks, dosing can be spaced out after the initial loading period. Cosentyx’s standard regimen includes an initial phase followed by maintenance dosing, consistent with its long half-life. [1]
Half-life can vary somewhat between individuals, but the commonly cited adult elimination half-life remains around 27 days. [1]
Other Questions About Cosentyx :